Pharma

CytoTronics Secures $13.5M Series Seed 2 Financing to Speed Market Entry of Pixel System for Breakthroughs in Cell Biology

September 6, 2024

Outcome Capital Continues to Expand with the Addition of Charles Simmons

August 7, 2024

AeroShield Materials Announces Opening of New Manufacturing Facility, $5M Additional Funding to Produce Cutting-Edge, Energy Efficient Technology for Built Environment

July 29, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan)

Vetter’s European Clinical Site Successfully Completes First 100 Aseptic Fills

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer’s Disease

Most Read

Blue Matter Acquires Sam Brown Inc., a Leading Healthcare Corporate Communications and Public Relations Agency

IMIDomics, Inc. Appoints Life Sciences Industry Leader Matthias Evers, Ph.D., to Board of Directors

Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDG

University of Rochester Medical Center Boosts Diagnostic Accuracy and Workflow Efficiency with Butterfly Network’s Enterprise Ultrasound Solution

EDITOR PICKS